Hetlioz
Total Payments
$4.7M
Transactions
7,055
Doctors
3,181
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $233,560 | 3,227 | 1,609 |
| 2018 | $1.8M | 3,140 | 1,691 |
| 2017 | $2.7M | 688 | 530 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $4.5M | 157 | 95.6% |
| Food and Beverage | $123,162 | 6,883 | 2.6% |
| Grant | $60,000 | 1 | 1.3% |
| Charitable Contribution | $20,000 | 1 | 0.4% |
| Consulting Fee | $2,800 | 2 | 0.1% |
| Travel and Lodging | $524.47 | 1 | 0.0% |
| Education | $173.88 | 10 | 0.0% |
Payments by Type
Research
$4.5M
157 transactions
General
$206,660
6,898 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| An Observational Study to Investigate the Effects of Rapid Transmeridian Travel | Vanda Pharmaceuticals Inc. | $1.9M | 0 |
| Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia | Vanda Pharmaceuticals Inc. | $1.8M | 1 |
| Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS | Vanda Pharmaceuticals Inc. | $480,510 | 0 |
| A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder | Vanda Pharmaceuticals Inc. | $189,449 | 0 |
| Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents | Vanda Pharmaceuticals Inc. | $165,227 | 1 |
| The Study of Genetic Variation Associated with Sleep Patterns | Vanda Pharmaceuticals Inc. | $787.50 | 0 |
Top Doctors Receiving Payments for Hetlioz — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Psychiatry | New York, NY | $255.79 | 10 |
| , M.D | Psychiatry | New York, NY | $255.79 | 10 |
| , MD | Psychiatry | Ocala, FL | $254.55 | 14 |
| Rakesh Ranjan | Psychiatry | Brecksville, OH | $247.55 | 14 |
| , MD | Psychiatry | Randolph, MA | $245.49 | 15 |
| , MD | Psychiatry | Miami, FL | $245.07 | 12 |
| , M.D | Psychiatry | Charleston, WV | $244.12 | 11 |
| , MD | Psychiatry | Randolph, MA | $243.23 | 19 |
| , M.D., PH.D, DABPN | Child & Adolescent Psychiatry | San Diego, CA | $240.58 | 13 |
| , MD | Psychiatry | Charleston, WV | $239.33 | 21 |
| , MD | Internal Medicine | Low Moor, VA | $238.73 | 11 |
| , MD | Psychiatry | Lawrence, MA | $238.22 | 31 |
| , M.D | Psychiatry | Albany, NY | $235.68 | 9 |
| , M.D | Addiction Medicine | New York, NY | $235.46 | 9 |
| , MD | Psychiatry | Beckley, WV | $235.05 | 12 |
| , MD | Internal Medicine | Bridgeport, CT | $232.94 | 21 |
| , M.D | Psychiatry | Coldwater, MI | $231.89 | 11 |
| , DO | Psychiatry | Manchester, NH | $226.43 | 12 |
| , M.D | Psychiatry | Bluefield, WV | $220.44 | 8 |
| , D.D.S | General Practice | Dafter, MI | $214.71 | 30 |
| , M.D | Psychiatry | Bedford, MA | $213.33 | 15 |
| , M.D | Psychiatry | Woodbury, CT | $212.63 | 11 |
| , M.D | Psychiatry | Exeter, NH | $211.60 | 13 |
| , M.D | Psychiatry | Peterborough, NH | $210.60 | 12 |
| , MD | Psychiatry | New York, NY | $208.78 | 11 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $4.7M
- Total Doctors 3,181
- Transactions 7,055
About Hetlioz
Hetlioz is a drug associated with $4.7M in payments to 3,181 healthcare providers, recorded across 7,055 transactions in the CMS Open Payments database. The primary manufacturer is Vanda Pharmaceuticals Inc..
Payment data is available from 2017 to 2019. In 2019, $233,560 was paid across 3,227 transactions to 1,609 doctors.
The most common payment nature for Hetlioz is "Unspecified" ($4.5M, 95.6% of total).
Hetlioz is associated with 6 research studies, including "An Observational Study to Investigate the Effects of Rapid Transmeridian Travel" ($1.9M).